Board Meeting Outcome for Intimation of Audited Financial Results under Regulation 33 of Listing Regulations.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Global Health Limited (Medanta) reported consolidated revenue of ₹44,103 million for FY2026, up 15.8% from ₹36,923 million in FY2025. Standalone revenue grew to ₹37,094 million from ₹32,041 million. Consolidated PAT increased to ₹5,541 million from ₹4,813 million (15.1% growth). The company recommended a final dividend of ₹0.50 per share (25% on face value of ₹2). Statutory auditors Walker Chandiok & Co LLP issued an unmodified report with no qualifications. Exceptional items of ₹10.21 million (net) for the year include labor code impact of ₹365.98 million partially offset by EPCG reversal of ₹195.92 million.
Revenue and profit growth of around 15-16% are healthy but below high-growth thresholds. Unmodified auditor opinion and strong operating cash flow of ₹7,144 million are positives. The dividend signals confidence, and expansion plans in Varanasi and Indore indicate growth focus.